Germany
Japan
United Kingdom
China
Antibodies
ADFP (PLIN2) (5-27) mouse monoclonal antibody, clone AP125, Purified
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Rat |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Fibroblasts (Pan Reticular) rat monoclonal antibody, clone ER-TR7, Purified
| Applications | FC, IF, IHC |
| Reactivities | Human, Mouse |
USD 250.00
2 Weeks
USD 415.00
2 Weeks
Adeno-associated Virus / AAV (VP1 + VP2 + VP3) mouse monoclonal antibody, clone B1, Purified
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
USD 475.00
2 Weeks
EPCAM mouse monoclonal antibody, clone HEA125, FITC
| Applications | IF, IHC |
| Reactivities | Human |
| Conjugation | FITC |
USD 260.00
2 Weeks
gamma Tubulin (TUBG1) (434-449) mouse monoclonal antibody, clone TU-32, Aff - Purified
| Applications | ELISA, IF, WB |
| Reactivities | Mammalian, Plant |
Tyrosine Hydroxylase (TH) mouse monoclonal antibody, clone LNC1
| Applications | IF, IHC, WB |
| Reactivities | All Species |
| Conjugation | Unconjugated |
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
pan Dengue Virus mouse monoclonal antibody, clone Dengue 1-11(3), Purified
| Applications | ELISA, IF, IHC, WB |
USD 230.00
2 Weeks
Hantavirus (Puumala Nucleocapsid) mouse monoclonal antibody, clone A1C5, Supernatant
| Applications | IF, IHC, WB |
Testosterone (3-CMO-BSA) mouse monoclonal antibody, clone 7003, Purified
| Applications | ELISA, IF, R |
| Reactivities | Human |
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 220.00
2 Weeks
p75 NGF Receptor (NGFR) (1-160) mouse monoclonal antibody, clone NGFR5, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Feline, Ferret, Human, Monkey, Rabbit |
C1QA mouse monoclonal antibody, clone JL-1, Biotin
| Applications | ELISA, FN, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
USD 420.00
In Stock
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
USD 340.00
2 Weeks
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone KS19.2(Z105.6), Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Amphibian, Bovine, Chicken, Human, Rat |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
Synaptopodin (SYNPO) mouse monoclonal antibody, clone G1D4, Supernatant
| Applications | IF, IHC, WB |
| Reactivities | Bovine, Guinea Pig, Human, Mouse, Rat |
Tubulin (TUBA1B) (Tyr-Tubulin) rat monoclonal antibody, clone YL1/2, Purified
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Birds, Mammalian, Yeast |
EPCAM mouse monoclonal antibody, clone 323/A3, Aff - Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD82 mouse monoclonal antibody, clone C33, Aff - Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Human |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- IF
Clonalities
- Monoclonal
Filter by
Target Symbol
- MAP2K1 (202)
- PDCD1 (136)
- CTAG1B (131)
- MAP2K3 (130)
- KLK8 (105)
- LIPG (105)
- TP53 (99)
- ERCC1 (96)
- MAPK13 (88)
- L1CAM (83)
- ERBB2 (82)
- PNMT (82)
- CDKN2A (81)
- MDM4 (75)
- VIM (75)
- PECAM1 (64)
- BSG (60)
- IDO1 (60)
- LOX (60)
- MLANA (60)
- PTPRE (60)
- EPCAM (59)
- APP (57)
- ACAT2 (55)
- BUB1B (55)
- CCT8L2 (55)
- CD163 (55)
- CTNNB1 (55)
- MAPK7 (55)
- MIOX (55)
- MOB3B (55)
- MTRF1L (55)
- NME4 (55)
- NPR3 (55)
- PDE4A (55)
- PSMC3 (55)
- SENP2 (55)
- CD19 (54)
- MAPRE2 (53)
- SQSTM1 (53)
- CDK2 (51)
- RNF144B (51)
- BTK (50)
- BTN1A1 (50)
- CHGA (50)
- FAHD2A (50)
- GFAP (50)
- IGF2BP2 (50)
- LENG1 (50)
- LIMK1 (50)
- MCL1 (50)
- PIK3AP1 (50)
- SMS (50)
- SPG7 (50)
- SYP (50)
- TACC3 (50)
- UBE2G2 (50)
- VWA5A (50)
- KRT7 (47)
- SNAP25 (47)
- CD80 (46)
- ERG (46)
- SNX9 (46)
- ALDH1L1 (45)
- ARHGAP25 (45)
- BECN1 (45)
- CCM2 (45)
- CD1C (45)
- ELK3 (45)
- FOXI1 (45)
- GBP2 (45)
- HIBCH (45)
- HOXC11 (45)
- PARVA (45)
- PGAM2 (45)
- PIK3R5 (45)
- SOCS3 (45)
- TAL1 (45)
- AKT1 (44)
- ERCC4 (44)
- ATP5F1B (41)
- POR (41)
- ACAA2 (40)
- AFP (40)
- ARFGAP1 (40)
- CD33 (40)
- CRYAB (40)
- DTYMK (40)
- DYNC1LI1 (40)
- LRATD2 (40)
- MICAL1 (40)
- NHEJ1 (40)
- PRKAR2A (40)
- PRKCE (40)
- PYCR2 (40)
- PYCR3 (40)
- RALBP1 (40)
- RASSF1 (40)
- RFXANK (40)
- SAMHD1 (40)
Reactivities
- Human (17783)
- Mouse (11242)
- Rat (10794)
- Monkey (2582)
- Dog (2252)
- Bovine (45)
- Hamster (36)
- Porcine (33)
- Primate (21)
- Rabbit (21)
- Canine (20)
- Chicken (20)
- Sheep (18)
- Zebrafish (10)
- Drosophila (9)
- Mammalian (9)
- Feline (8)
- Goat (8)
- SARS-CoV (8)
- Xenopus (8)
- Cow (6)
- Guinea Pig (6)
- Pig (6)
- Avian (4)
- Equine (4)
- C. elegans (3)
- All Species (2)
- Chimpanzee (2)
- Dengue virus (2)
- Fish (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- Beluga (1)
- Carp (1)
- Chlamydomonas (1)
- Drosophila melanogaster (1)
Antibody Hosts
Isotypes
- IgG1 (12666)
- IgG2a (4067)
- IgG2b (3294)
- IgG (376)
- IgG3 (142)
- IgG1, kappa (122)
- IgG, kappa (118)
- IgM (111)
- IgG2a, kappa (42)
- IgG2b, kappa (16)
- Fab fragment, kappa (12)
- IgG2 (11)
- IgM, kappa (11)
- IgG1, lambda (5)
- cocktail (3)
- IgA (2)
- IgG2a, lambda (2)
- IgG1/IgK (1)
- IgG2b, lambda (1)
- IgG3, kappa (1)
- IgG4 (1)
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (32)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- Phospho-specific (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (10616)
- Transmembrane (3190)
- Transcription Factors (2312)
- Protein Kinase (1585)
- ES Cell Differentiation/IPS (1486)
- Secreted Protein (1266)
- Protease (671)
- Stem cell - Pluripotency (656)
- Adult stem cells (273)
- Phosphatase (209)
- P450 (168)
- Embryonic stem cells (153)
- Stem cell relevant signaling - JAK/STAT signaling pathway (129)
- Ion Channels: Other (109)
- Stem cell relevant signaling - DSL/Notch pathway (105)
- Cancer stem cells (101)
- Induced pluripotent stem cells (91)
- Nuclear Hormone Receptor (78)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (57)
- GPCR (40)
- Ion Channels: Potassium (35)
- Stem cell relevant signaling - Wnt Signaling pathway (27)
- Ion Channels: Calcium (1)
- Ion Channels: Cyclic nucleotide gated (1)
- Ion Channels: Sodium (1)
- Ion Channels: Transient receptor potential (1)
Pathways
- Metabolic pathways (2242)
- Pathways in cancer (1483)
- MAPK signaling pathway (1196)
- Focal adhesion (860)
- Neurotrophin signaling pathway (860)
- Prostate cancer (834)
- Pancreatic cancer (798)
- Fc epsilon RI signaling pathway (793)
- Toll-like receptor signaling pathway (792)
- Progesterone-mediated oocyte maturation (783)
- T cell receptor signaling pathway (775)
- Non-small cell lung cancer (772)
- Chronic myeloid leukemia (765)
- Endometrial cancer (740)
- Melanoma (739)
- ErbB signaling pathway (724)
- Colorectal cancer (717)
- Insulin signaling pathway (708)
- Bladder cancer (700)
- Glioma (699)
- Regulation of actin cytoskeleton (694)
- GnRH signaling pathway (662)
- B cell receptor signaling pathway (610)
- Fc gamma R-mediated phagocytosis (595)
- Acute myeloid leukemia (577)
- VEGF signaling pathway (549)
- Gap junction (548)
- Renal cell carcinoma (546)
- Cell adhesion molecules (CAMs) (540)
- Cell cycle (526)
- Chemokine signaling pathway (519)
- Thyroid cancer (510)
- Natural killer cell mediated cytotoxicity (478)
- Apoptosis (446)
- Leukocyte transendothelial migration (443)
- Oocyte meiosis (420)
- p53 signaling pathway (416)
- Amyotrophic lateral sclerosis (ALS) (406)
- Purine metabolism (399)
- Jak-STAT signaling pathway (384)
- Small cell lung cancer (360)
- Melanogenesis (352)
- Hematopoietic cell lineage (346)
- Huntington's disease (338)
- Wnt signaling pathway (337)
- Alzheimer's disease (333)
- Vascular smooth muscle contraction (326)
- Endocytosis (323)
- Long-term depression (322)
- Prion diseases (319)
- Long-term potentiation (315)
- Adherens junction (308)
- Axon guidance (298)
- Type II diabetes mellitus (277)
- Ubiquitin mediated proteolysis (273)
- Tight junction (268)
- Dorso-ventral axis formation (259)
- Pathogenic Escherichia coli infection (257)
- Parkinson's disease (247)
- Pyrimidine metabolism (242)
- Glycolysis / Gluconeogenesis (238)
- mTOR signaling pathway (238)
- Valine (233)
- Epithelial cell signaling in Helicobacter pylori infection (230)
- Primary immunodeficiency (230)
- leucine and isoleucine degradation (222)
- Adipocytokine signaling pathway (212)
- Cytokine-cytokine receptor interaction (203)
- Nucleotide excision repair (193)
- Basal cell carcinoma (190)
- NOD-like receptor signaling pathway (183)
- Systemic lupus erythematosus (183)
- Arginine and proline metabolism (181)
- Glycerolipid metabolism (181)
- TGF-beta signaling pathway (177)
- Tryptophan metabolism (177)
- Tyrosine metabolism (170)
- RIG-I-like receptor signaling pathway (169)
- Oxidative phosphorylation (167)
- Calcium signaling pathway (164)
- Proteasome (144)
- Drug metabolism - cytochrome P450 (143)
- Pyruvate metabolism (143)
- Arachidonic acid metabolism (134)
- Fatty acid metabolism (132)
- Metabolism of xenobiotics by cytochrome P450 (132)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (126)
- beta-Alanine metabolism (125)
- Propanoate metabolism (124)
- Viral myocarditis (124)
- Antigen processing and presentation (119)
- Type I diabetes mellitus (117)
- Graft-versus-host disease (115)
- Butanoate metabolism (113)
- Glycine (110)
- serine and threonine metabolism (110)
- Glutathione metabolism (109)
- Fructose and mannose metabolism (107)
- Citrate cycle (TCA cycle) (102)
- Inositol phosphate metabolism (101)
- PPAR signaling pathway (99)
- Phosphatidylinositol signaling system (98)
- Cysteine and methionine metabolism (95)
- Retinol metabolism (95)
- Maturity onset diabetes of the young (94)
- Hypertrophic cardiomyopathy (HCM) (88)
- Lysine degradation (88)
- Pentose phosphate pathway (87)
- Regulation of autophagy (87)
- Terpenoid backbone biosynthesis (87)
- Linoleic acid metabolism (84)
- Amino sugar and nucleotide sugar metabolism (81)
- Base excision repair (79)
- Dilated cardiomyopathy (76)
- Neuroactive ligand-receptor interaction (76)
- Vibrio cholerae infection (75)
- Allograft rejection (71)
- Synthesis and degradation of ketone bodies (70)
- Cytosolic DNA-sensing pathway (69)
- Notch signaling pathway (67)
- Autoimmune thyroid disease (66)
- Cardiac muscle contraction (63)
- Ascorbate and aldarate metabolism (61)
- Complement and coagulation cascades (60)
- Lysosome (60)
- Mismatch repair (60)
- One carbon pool by folate (60)
- RNA degradation (57)
- Spliceosome (56)
- Galactose metabolism (55)
- Caffeine metabolism (53)
- Starch and sucrose metabolism (52)
- RNA polymerase (51)
- SNARE interactions in vesicular transport (51)
- DNA replication (50)
- Hedgehog signaling pathway (50)
- Histidine metabolism (48)
- Non-homologous end-joining (48)
- Drug metabolism - other enzymes (47)
- Nicotinate and nicotinamide metabolism (46)
- Homologous recombination (43)
- Fatty acid elongation in mitochondria (41)
- N-Glycan biosynthesis (40)
- Alanine (36)
- Folate biosynthesis (36)
- aspartate and glutamate metabolism (36)
- Sphingolipid metabolism (33)
- ECM-receptor interaction (31)
- Glycosaminoglycan degradation (30)
- Renin-angiotensin system (30)
- Porphyrin and chlorophyll metabolism (29)
- Other glycan degradation (28)
- Biosynthesis of unsaturated fatty acids (27)
- Glyoxylate and dicarboxylate metabolism (25)
- Nitrogen metabolism (25)
- Sulfur metabolism (25)
- Circadian rhythm - mammal (22)
- Pantothenate and CoA biosynthesis (22)
- Methane metabolism (18)
- Basal transcription factors (17)
- Primary bile acid biosynthesis (17)
- Androgen and estrogen metabolism (16)
- Glycosphingolipid biosynthesis - ganglio series (15)
- Glycosphingolipid biosynthesis - lacto and neolacto series (15)
- Keratan sulfate biosynthesis (15)
- Phenylalanine metabolism (15)
- Selenoamino acid metabolism (15)
- Vitamin B6 metabolism (15)
- Asthma (13)
- Glycerophospholipid metabolism (12)
- Olfactory transduction (12)
- leucine and isoleucine biosynthesis (11)
- Steroid biosynthesis (10)
- Taurine and hypotaurine metabolism (10)
- Fatty acid biosynthesis (8)
- Limonene and pinene degradation (8)
- Aminoacyl-tRNA biosynthesis (6)
- Pentose and glucuronate interconversions (5)
- ABC transporters (3)
- Riboflavin metabolism (3)
- C21-Steroid hormone metabolism (1)
- Ribosome (1)